Advertisement
Screener

IDEXX LABORATORIES INC /DE (IDXX) Increase (Decrease) in Deferred Compensation

2.8 / 5 stars · 68/120 Roast Me

IDEXX LABORATORIES INC /DE Increase (Decrease) in Deferred Compensation

IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Deferred Compensation of $58.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-28.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2015-04-28

  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for the quarter ending 2015-03-31 was $58.00K.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for the quarter ending 2014-06-30 was $93.00K.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for the quarter ending 2014-03-31 was -$86.00K, a 175.44% decline year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for the quarter ending 2013-12-31 was $218.00K, a 2625.00% increase year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for fiscal 2013 was $444.00K, a 141.30% increase from fiscal 2012.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for fiscal 2012 was $184.00K.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for fiscal 2011 was -$171.00K, a 158.97% decline from fiscal 2010.
  • IDEXX LABORATORIES INC /DE increase (decrease) in deferred compensation for fiscal 2010 was $290.00K, a 40.08% decline from fiscal 2009.
Period endIncrease (Decrease) in Deferred Compensation 3 monthIncrease (Decrease) in Deferred Compensation 6 monthIncrease (Decrease) in Deferred Compensation 9 monthIncrease (Decrease) in Deferred Compensation 12 month
2015-03-31$58.00K
10-Q · filed 2015-04-28
2014-06-30$93.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25
$7.00K
10-Q · filed 2014-07-25
$225.00K
derived: sum of 3 quarters · filed 2015-04-28
$362.00K
derived: sum of 4 quarters · filed 2015-04-28
2014-03-31-$86.00K
10-Q · filed 2015-04-28
$132.00K
derived: sum of 2 quarters · filed 2015-04-28
$269.00K
derived: sum of 3 quarters · filed 2015-04-28
$244.00K
derived: sum of 4 quarters · filed 2015-04-28
2013-12-31$218.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$355.00K
derived: sum of 2 quarters · filed 2014-02-18
$330.00K
derived: sum of 3 quarters · filed 2014-07-25
$444.00K
10-K · filed 2014-02-18
2013-09-30$137.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22
$112.00K
derived: sum of 2 quarters · filed 2014-07-25
$226.00K
10-Q · filed 2013-10-22
$234.00K
derived: sum of 4 quarters · filed 2014-07-25
2013-06-30-$25.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25
$89.00K
10-Q · filed 2014-07-25
$97.00K
derived: sum of 3 quarters · filed 2014-07-25
$185.00K
derived: sum of 4 quarters · filed 2014-07-25
2013-03-31$114.00K
10-Q · filed 2014-04-25
$122.00K
derived: sum of 2 quarters · filed 2014-04-25
$210.00K
derived: sum of 3 quarters · filed 2014-04-25
$122.00K
derived: sum of 4 quarters · filed 2014-04-25
2012-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$96.00K
derived: sum of 2 quarters · filed 2014-02-18
$8.00K
derived: sum of 3 quarters · filed 2014-02-18
$184.00K
10-K · filed 2014-02-18
2012-09-30$88.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22
$0.00
derived: sum of 2 quarters · filed 2013-10-22
$176.00K
10-Q · filed 2013-10-22
$325.00K
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30-$88.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23
$88.00K
10-Q · filed 2013-07-23
$237.00K
derived: sum of 3 quarters · filed 2014-02-18
-$154.00K
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$176.00K
10-Q · filed 2013-04-23
$325.00K
derived: sum of 2 quarters · filed 2014-02-18
-$66.00K
derived: sum of 3 quarters · filed 2014-02-18
-$83.00K
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31$149.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
-$242.00K
derived: sum of 2 quarters · filed 2014-02-18
-$259.00K
derived: sum of 3 quarters · filed 2014-02-18
-$171.00K
10-K · filed 2014-02-18
2011-09-30-$391.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19
-$408.00K
derived: sum of 2 quarters · filed 2012-10-19
-$320.00K
10-Q · filed 2012-10-19
-$165.00K
derived: sum of 4 quarters · filed 2013-02-19
2011-06-30-$17.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20
$71.00K
10-Q · filed 2012-07-20
$226.00K
derived: sum of 3 quarters · filed 2013-02-19
$432.00K
derived: sum of 4 quarters · filed 2013-02-19
2011-03-31$88.00K
10-Q · filed 2012-04-20
$243.00K
derived: sum of 2 quarters · filed 2013-02-19
$449.00K
derived: sum of 3 quarters · filed 2013-02-19
$277.00K
derived: sum of 4 quarters · filed 2013-02-19
2010-12-31$155.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19
$361.00K
derived: sum of 2 quarters · filed 2013-02-19
$189.00K
derived: sum of 3 quarters · filed 2013-02-19
$290.00K
10-K · filed 2013-02-19
2010-09-30$206.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21
$34.00K
derived: sum of 2 quarters · filed 2011-10-21
$135.00K
10-Q · filed 2011-10-21
$249.00K
derived: sum of 4 quarters · filed 2012-02-17
2010-06-30-$172.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22
-$71.00K
10-Q · filed 2011-07-22
$43.00K
derived: sum of 3 quarters · filed 2012-02-17
$254.00K
derived: sum of 4 quarters · filed 2012-02-17
2010-03-31$101.00K
10-Q · filed 2011-04-21
$215.00K
derived: sum of 2 quarters · filed 2012-02-17
$426.00K
derived: sum of 3 quarters · filed 2012-02-17
2009-12-31$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17
$325.00K
derived: sum of 2 quarters · filed 2012-02-17
$484.00K
10-K · filed 2012-02-17
2009-09-30$211.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22
$370.00K
10-Q · filed 2010-10-22
2009-06-30$159.00K
10-Q · filed 2010-07-23
2008-12-31-$726.00K
10-K · filed 2011-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lantheus Holdings, Inc. (LNTH)United States$6.510B26.31
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10